South Korea To Allow Medical Cannabis Imports Starting In March

Almost three months after the legalization of medical marijuana, the South Korean government is moving forward and plans to allow imports of weed starting next month.

What Happened

The Ministry of Food and Drug Safety said Tuesday that the National Assembly passed a bill to amend a law that would allow imports and exports of non-hallucinogenic doses of medical marijuana. 

In November, the country's National Assembly voted on amendments to the Act on the Management of Narcotic Drugs after the country's Ministry of Food and Drug Safety said in July that it would allow patients to be prescribed the cannabis-based drugs Epidiolex, Marinol, Cesamet and Sativex for a number of conditions including epilepsy and HIV/AIDS.

Why It's Important

Tuesday's news represents a small step for marijuana in South Korea. Despite the legalization, access to medical marijuana will be restricted and decided on a case-by-case basis. Patients will be required to apply to the Korea Orphan Drug Center and will need a prescription from a doctor.

The country also maintains some of the strictest recreational consumption laws, with citizens risking prosecution even if they consume cannabis in other countries where weed is legal. 

What's Next

The law takes effect March 12. In the meantime, The Organization of Legalizing Medical Cannabis in Korea — a lobbying and advocacy group created last year — plans to persuade the government to expand the number of diseases that would qualify a patient to receive medical marijuana. 

Related Links:

Thailand Breaks Medical Marijuana Barrier In Southeast Asia

Israel To Allow Medical Marijuana Exports

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Cannabis is evolving – don’t get left behind!

Curious about what’s next for the industry and how to leverage California’s unique market?

Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!

Get your tickets now to secure your spot and avoid last-minute price hikes.